PerturbAI Emerges from Stealth with 8-Million-Cell In Vivo CRISPR Atlas
San Francisco-based PerturbAI has launched from stealth, unveiling what it calls the world’s largest in vivo CRISPR atlas, announced in a press release. The dataset spans eight million brain-wide cells and was created in collaboration with NVIDIA, the Allen Institute for Brain Science, and 10x Genomics.
The atlas maps the effects of thousands of genetic perturbations across hundreds of neuronal cell types in the mouse brain, offering a large-scale resource for understanding gene function in living tissue. PerturbAI’s in vivo CRISPR platform measures gene activity within intact organs, capturing biological circuitry instead of isolated cell states.
According to the company, the dataset enables a systems-level view of gene function and supports the development of AI models capable of predicting biological responses across diverse cellular contexts. The data and accompanying manuscript are available through PerturbAI’s blog, Hugging Face, and the NVIDIA AI Blueprint for Single-Cell Analysis.
PerturbAI said it will use the platform and its causal AI models to advance therapeutics targeting complex metabolic and chronic diseases. The company completed an oversubscribed pre-seed funding round in the third quarter of 2025.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ARPA-H Funds $28.6 Million AI Protein Research Project
Illumina Launches BioInsight Platform for Genomic Research
Insilico Medicine Opens AI Longevity Research Toolkit
INmune Bio and QCi Apply Quantum Computing to XPro Research
Illumina releases SpliceAI2 for genetic variant research
Daily AI Brief: the AI news that matters, in your inbox.